Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

348

HTML

3245

Figures (1-1)

133

Tables (1-4)

141

Sum=3867

Nov 28, 2011 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Nov 28, 2011; 17(44): 4917-4921
Published online Nov 28, 2011. doi: 10.3748/wjg.v17.i44.4917

Table 4 Combined analysis of methylation and recurrence in esophageal squamous cell carcinoma patients

¹Adjusted for age, gender, smoking, drinking, stage, surgical operation and chemo-/radio-therapy. CI: Confidence intervals; OR: Odds ratios.

Citation: Liu JB, Qiang FL, Dong J, Cai J, Zhou SH, Shi MX, Chen KP, Hu ZB. Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(44): 4917-4921
URL: https://www.wjgnet.com/1007-9327/full/v17/i44/4917.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i44.4917